These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16203601)

  • 1. Fetal and neonatal consequences of antenatal exposure to type 1 angiotensin II receptor-antagonists.
    Vendemmia M; Garcia-Méric P; Rizzotti A; Boubred F; Lacroze V; Liprandi A; Simeoni U
    J Matern Fetal Neonatal Med; 2005 Aug; 18(2):137-40. PubMed ID: 16203601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal acute renal failure secondary to maternal exposure to telmisartan, angiotensin II receptor antagonist.
    Pietrement C; Malot L; Santerne B; Roussel B; Motte J; Morville P
    J Perinatol; 2003; 23(3):254-5. PubMed ID: 12732865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists.
    Quan A
    Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection.
    Barr M; Cohen MM
    Teratology; 1991 Nov; 44(5):485-95. PubMed ID: 1771591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe neonatal renal failure after maternal use of angiotensin II type I receptor antagonists.
    Sinelli MT; Cattarelli D; Cortinovis S; Maroccolo D; Chirico G
    Pediatr Med Chir; 2008; 30(6):306-8. PubMed ID: 19431954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II receptor antagonist treatment during pregnancy.
    Alwan S; Polifka JE; Friedman JM
    Birth Defects Res A Clin Mol Teratol; 2005 Feb; 73(2):123-30. PubMed ID: 15669052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II-receptor-antagonists: further evidence of fetotoxicity but not teratogenicity.
    Schaefer C
    Birth Defects Res A Clin Mol Teratol; 2003 Aug; 67(8):591-4. PubMed ID: 14632309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal toxic effects of angiotensin II receptor antagonists: case report and follow-up after birth.
    Bos-Thompson MA; Hillaire-Buys D; Muller F; Dechaud H; Mazurier E; Boulot P; Morin D
    Ann Pharmacother; 2005 Jan; 39(1):157-61. PubMed ID: 15590878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Roger N; Popovic I; Madelenat P; Mahieu-Caputo D
    Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal anuria with maternal angiotensin-converting enzyme inhibition.
    Rosa FW; Bosco LA; Graham CF; Milstien JB; Dreis M; Creamer J
    Obstet Gynecol; 1989 Sep; 74(3 Pt 1):371-4. PubMed ID: 2761913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure.
    Chisholm CA; Chescheir NC; Kennedy M
    Am J Perinatol; 1997 Oct; 14(9):511-3. PubMed ID: 9394157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taking ACE inhibitors during pregnancy. Is it safe?
    Ratnapalan S; Koren G
    Can Fam Physician; 2002 Jun; 48():1047-9. PubMed ID: 12113190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational therapy with an angiotensin II receptor antagonist and transient renal failure in a premature infant.
    Bass JK; Faix RG
    Am J Perinatol; 2006 Jul; 23(5):313-7. PubMed ID: 16799914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitor fetopathy.
    Pryde PG; Sedman AB; Nugent CE; Barr M
    J Am Soc Nephrol; 1993 Mar; 3(9):1575-82. PubMed ID: 8507813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension in pregnancy. ACE inhibitors and angiotensin II receptor antagonists are contraindicated because of their potential fetotoxicity].
    Partosch F; Stahlmann R
    Med Monatsschr Pharm; 2011 Oct; 34(10):358-62. PubMed ID: 22010419
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Mar; 46(11):240-2. PubMed ID: 9082178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition and management of angiotensin converting enzyme inhibitor fetopathy.
    Sedman AB; Kershaw DB; Bunchman TE
    Pediatr Nephrol; 1995 Jun; 9(3):382-5. PubMed ID: 7632538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal neonatal renal failure due to maternal enalapril ingestion.
    Murki S; Kumar P; Dutta S; Narang A
    J Matern Fetal Neonatal Med; 2005 Mar; 17(3):235-7. PubMed ID: 16147831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors.
    Piper JM; Ray WA; Rosa FW
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):429-32. PubMed ID: 1495700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Teratogenic effects of ACE-inhibitors and angiotensin II receptor antagonists].
    Sørensen AM; Christensen S; Jonassen TE; Andersen D; Petersen JS
    Ugeskr Laeger; 1998 Mar; 160(10):1460-4. PubMed ID: 9520613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.